首页> 外文期刊>Veterinary Parasitology >The efficacy of eprinomectin extended-release injection against Hypoderma spp. (Diptera: Oestridae) in cattle
【24h】

The efficacy of eprinomectin extended-release injection against Hypoderma spp. (Diptera: Oestridae) in cattle

机译:依普诺菌素缓释注射液对木霉菌的功效。牛(双翅目:Oestridae)

获取原文
获取原文并翻译 | 示例
       

摘要

The efficacy of eprinomectin in an extended-release injection (ERI) formulation was determined in cattle harboring naturally acquired infestations of first-or second- and third-stage larvae of Hypoderma spp. in three studies conducted according to the same protocol in the USA (two studies) and Germany (one study). Thirty cattle sourced from herds with a history of Hypoderma infestation were included in each study. Cattle were formed into replicates of three animals each on the basis of pre-treatment anti-Hypoderma antibody titers. Within replicates each animal was randomly allocated to one of the following treatments: ERI vehicle (control) at 1 mL/50 kg bodyweight, administered once on Day 0; Eprinomectin 5% ERI at 1 mL/50 kg bodyweight (1.0 mg eprinomectin/kg), administered once on Day 0 (when larvae were expected to be first instars); or Eprinomectin 5% ERI at 1 mL/50 kg bodyweight (1.0 mg eprinomectin/kg), administered once when larvae were second or third instars (study dependent, Day 73, 119, or 140). Treatments were administered by subcutaneous injection in front of the shoulder. In all studies, emerging and/or expressed Hypoderma larvae were recovered, speciated, and counted and viability was determined. Eprinomectin LAI treatment was 100% (p <0.05) efficacious against first- and second- or third-stage larvae of Hypoderma bovis (two studies) and Hypoderma lineatum (one study). All animals accepted the treatment well. No adverse reaction to treatments was observed in any animal in any study
机译:依普利菌素在缓释注射液(ERI)制剂中的功效是在牛中自然吸食的Hypoderma spp的第一或第二和第三阶段幼虫感染的牛确定的。在美国(两项研究)和德国(一项研究)根据相同的方案进行的三项研究中。每项研究均包括30头牛,这些牛来自具有低等皮肤病史的牛群。基于预处理的抗-Hypoderma抗体效价,将牛形成三只动物的复制品。在重复实验中,将每只动物随机分配至以下处理之一:以1mL / 50kg体重的ERI媒介物(对照),在第0天给药一次;在第0天(预计幼虫为第一龄幼虫)第1天给药,以1 mL / 50 kg体重(1.0 mg eprinomectin / kg)施用5%Eprinomectin。或1毫升/ 50公斤体重的依普连菌素5%ERI(1.0毫克依普连菌素/千克),当幼虫为第二龄或第三龄幼虫时服用一次(取决于研究,第73、119或140天)。通过在肩前皮下注射进行治疗。在所有研究中,新兴的和/或表达的Hypoderma幼虫均被回收,鉴定和计数,并确定了生存力。柔和菌素LAI治疗对牛副葡萄球菌(两个研究)和次木霉(一个研究)的第一,第二或第三阶段幼虫有效(100%(p <0.05))。所有动物都很好地接受了治疗。在任何研究中,任何动物均未观察到对治疗的不良反应

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号